Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
|
CA |
|
Doxee SpA
MIL:DOX
|
IT |
|
Nova Minerals Ltd
NASDAQ:NVA
|
AU |
|
FocalTech Systems Co Ltd
TWSE:3545
|
TW |
|
Bt Brands Inc
NASDAQ:BTBD
|
US |
|
A
|
Atinum Investment Co Ltd
KOSDAQ:021080
|
KR |
|
H
|
Heineken Holding NV
XMUN:4H5
|
NL |
|
Reynolds Consumer Products Inc
NASDAQ:REYN
|
US |
|
R
|
REN Redes Energeticas Nacionais SGPS SA
F:RN4
|
PT |
|
K
|
Kao Corp
XMUN:KAO
|
JP |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
|
D
|
Deutsche Bank AG
BMV:DBN
|
DE |
|
A
|
Ameren Corp
F:AE4
|
US |
|
T
|
Thermo Fisher Scientific Inc
DUS:TN8
|
US |
|
D
|
Deutsche Telekom AG
DUS:DTE
|
DE |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
L
|
Lakeland Industries Inc
F:LLI
|
US |
|
I
|
Itochu Corp
XMUN:IOC
|
JP |
|
Grifols SA
OTC:GIKLY
|
ES |
|
T
|
Thales SA
F:CSF
|
FR |
|
International Paper Co
LSE:IPC
|
US |
|
A
|
AT&T Inc
F:SOBA
|
US |
|
Thales SA
F:CSF0
|
FR |
|
Equinor ASA
OSE:EQNR
|
NO |
Bankruptcy Probability
Eupraxia Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eupraxia Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
790.9m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
221.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eupraxia Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eupraxia Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.